daunorubicin has been researched along with Brachial Paresis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diehl, V; Glossmann, JP; Josting, A; Staak, JO; Wickenhauser, C | 1 |
| Abbrederis, K; Michlmayr, G; Schmalzl, F | 1 |
2 other study(ies) available for daunorubicin and Brachial Paresis
| Article | Year |
|---|---|
Extramedullary acute myeloid leukemia (granulocytic sarcoma) with arm paresis, maculopapular exanthema and organ involvement.
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Arm; Biomarkers, Tumor; Carboxylic Ester Hydrolases; Cerebral Hemorrhage; Cytarabine; Daunorubicin; Exanthema; Fatal Outcome; Humans; Leukosialin; Male; Mitoxantrone; Neoplasm Proteins; Paresis; Sarcoma, Myeloid; Sialoglycoproteins; Skin; Stomach; Testis; Thioguanine; Vimentin | 2003 |
[Acute lymphatic leukemia in adults. Therapy and prognosis in comparison with acute myelogenous leukemia].
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Asparaginase; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Middle Aged; Paresis; Prognosis; Radiotherapy Dosage; Remission, Spontaneous; Vincristine | 1974 |